Humacyte, Inc. ( HUMA) - Key Metrics
HUMA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0 | ? | $0.03 | $0.03 |
| 2025Q2 | $0 | -$0.24 | -$0.17 | -$0.17 |
| 2025Q1 | $0 | $0.30 | -$0.22 | -$0.22 |
HUMA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -2.16 |
| 2025Q1 | ? | 1.44 |
HUMA
Price: $1.03
52 week price:
Earnings Per Share: -0.63 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 166552
Market Capitalization: 226.8 million